Innate Pharma Up 4% After FDA Lifts Partial Clinical Hold on Lacutamab
By Josh Beckerman Innate Pharma's American depositary receipts were recently up 4%, to $2.89, after the Food and Drug Administration lifted a partial...
Source: marketwatch.com
Stay updated with breaking news from Iph Fr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Josh Beckerman Innate Pharma's American depositary receipts were recently up 4%, to $2.89, after the Food and Drug Administration lifted a partial...